Xinyuan Lei
Has grant
Research Assistant/Teaching Assistant
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Xinyuan Lei is a Research Assistant and Teaching Assistant at Stony Brook University in the United States. Their research focuses on tumor biology, immune escape mechanisms in solid tumors, and the role of non-coding RNAs in cancer metastasis and treatment response. Recent publications include studies on STAT3 in mutant KRAS contexts, retinoic acid signaling in immune cell differentiation, and the effects of histone deacetylase inhibitors on CAR T cell activity in solid tumors.
Recent Grants
Grant: Close
Mitochondrial Dynamin-related Protein 1 Regulates the Expression of MHC-I and Immunogenicity of TSCC (81872194)
Open Date: 2018-01-01
Close Date: 2023-06-01
Grant: Close
Mitochondrial Dynamin-related Protein 1 Regulates Mitochondrial Fission and Cisplatin Sensitivity of TSCC (2017A030313501)
Open Date: 2017-12-01
Close Date: 2021-03-01
Articles (6)
Year:
2025
CD8 tissue-resident memory T (TRM) cells provide frontline protection at barrier tissues; however, mechanisms regulating TRM cell development are not completely understood. Priming dictates the migration of effector T cells to the tissue, while factors in the tissue induce in situ TRM cell differentiation. Whether priming also regulates in situ TRM cell differentiation uncoupled from migration is unclear. Here, we demonstrate that T cell priming in the mesenteric lymph nodes (MLN) regulates CD103+ TRM cell differentiation in the intestine. In contrast, T cells primed in the spleen were impaired in the ability to differentiate into CD103+ TRM cells after entry into the intestine. MLN priming initiated a CD103+ TRM cell gene signature and licensed rapid CD103+ TRM cell differentiation in response to factors in the intestine. Licensing was regulated by retinoic acid signaling and primarily driven by factors other than CCR9 expression and CCR9-mediated gut homing. Thus, the MLN is specialized to promote intestinal CD103+ CD8 TRM cell development by licensing in situ differentiation.
Year:
2023
Year:
2022
Year:
2021
Year:
2021
Year:
2020
Collaborators (2)
Ananthan Sadagopan
Harvard University
Brian S. Sheridan
-
Make your next move.
Prepare your application
Review drafts before you send them.